|
|
Thomson Financial Business Description:
| The Group's principal activity is to manufacture, produce and distribute active pharmaceutical ingredients. The Group is also in the business of consumer healthcare products.The major products include Simvastatin, CoAmoxyclav, Amoxycillin, Ciprofloxacin, Isotretinon and Cephalexin. It has manufacturing facilities in eleven countries - Brazil, China, India, Ireland, Japan, Malaysia, Nigeria, Romania, South Africa, the United States of America and Vietnam. In January 2008, the Group acquired Vectra Pharmaceutical Private Limited. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Ranbaxy Laboratories Ltd.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
